Amylx Pharmaceuticals Inc vs Motorola Solutions Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Motorola Solutions Inc trades at $466.86 (market cap $77.26B). The key difference: Motorola Solutions Inc is far larger — about 29.3× Amylx Pharmaceuticals Inc's market cap, and Motorola Solutions Inc pays a 1.04% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | MSI | |
|---|---|---|
Market Cap | $2.64B | $77.26B |
Sector | Health | Technology |
52-Week High | $24.19 | $490.30 |
52-Week Low | $7.82 | $363.83 |
Enterprise Value | $2.39B | $86.17B |
Dividend Yield | — | 1.04% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →